• The continuing evolution of official statistics: some challenges and opportunities 

  MacFeely, Steve (De Gruyter Open, 2016-11)

  As economies, societies, and environments change, official statistics evolve and develop to reflect those changes. In reaction to disruptive innovations arising from globalisation, technological advances, and cultural ...
• Drug prescribing patterns in the General Medical Services Scheme in Ireland and projected costs to 2026 

  Conway Lenihan, Aisling (University College Cork, 2015)

  The primary objective is to investigate the main factors contributing to GMS expenditure on pharmaceutical prescribing and projecting this expenditure to 2026. This study is located in the area of pharmacoeconomic cost ...
• Irish GMS cost projections and its implications between 2016 and 2026 

  Conway Lenihan, Aisling; Woods, Noel (OMICS International, 2015-11-07)

  Introduction: Ireland had one of the highest pharmaceutical spends per capita in the EU in 2012. The General Medical Services (GMS) scheme is the largest community drug scheme in Ireland with approximately 40% of the ...
• Cost-outcome description of clinical pharmacist interventions in a university teaching hospital 

  Gallagher, James; Byrne, Stephen; Woods, Noel; Lynch, Deirdre; McCarthy, Suzanne (Biomed Central Ltd., 2014-04-17)

  Background: Pharmacist interventions are one of the pivotal parts of a clinical pharmacy service within a hospital. This study estimates the cost avoidance generated by pharmacist interventions due to the prevention of ...
• The implications of regional and national demographic projections for future GMS costs in Ireland through to 2026 

  Conway Lenihan, Aisling; Kenneally, Martin; Woods, Noel; Thummel, Andreas; Ryan, Marie (Biomed Central Ltd., 2014-10-21)

  BACKGROUND: As the health services in Ireland have become more resource-constrained, pressure has increased to reduce public spending on community drug schemes such as General Medical Services (GMS) drug prescribing and ...

View more